05/31
Headlines

Colin Pettis

Colin Pettis covers the senior semiconductor sector and is a managing director at Tech Insider, joining in 2012. Colin has 20 years of experience in equity research including 15 years in semiconductor components. Colin is currently responsible for the coverage of 18 large-cap and small-cap semiconductor companies.

Stocks In Bullish Zone: Johnson & Johnson (NYSE:JNJ), QUALCOMM (NASDAQ:QCOM), PepsiCo (NYSE:PEP), Baker Hughes Incorporated (NYSE:BHI)

Colin Pettis03 mins

New Brunswick, N.J.-based Johnson & Johnson (NYSE:JNJ) is probably most famous as the parent company of multiple household products that double as household names. Listing them all would require more space than is practical, but they include Band-Aid, Listerine, Splenda, Stayfree, Lubriderm, Visine, Purell, Mylanta, Bengay, and dozens upon dozens of others. Johnson & Johnson…

Read More

Solar Stocks To Watch; First Solar (NASDAQ:FSLR), NVIDIA Corporation (NASDAQ:NVDA), ARM Holdings (NASDAQ:ARMH), Cirrus Logic (NASDAQ:CRUS)

Colin Pettis03 mins

On March 21, Nevada Business published a photograph showing Reid breaking ground on a project with representatives of the Moapa Band of Paiutes, executives with First Solar Inc. (NASDAQ:FSLR) and representatives of the Los Angeles Department of Water and Power. The 250 megawatt Moapa Southern Paiute Solar Project is planned to deliver renewable energy to…

Read More

Eye-catching Stocks: Nokia Corporation (ADR) (NYSE:NOK), Hanwha Solarone (NASDAQ:HSOL), ReneSola (NYSE:SOL), Yingli Green Energy (ADR) (NYSE:YGE)

Colin Pettis02 mins

Nokia Corporation (ADR) (NYSE:NOK) issued an advisory for customers in the US and parts of Europe warning them of electric shock from a battery charger meant for its Lumia tablet 2520 due to a defect by its vendor. Nokia Corporation (ADR) (NYSE:NOK) stock performance was 0.55% in last session and finished the day at $7.34….

Read More

Biotech Volatile Stocks: Lexicon Pharmaceuticals (NASDAQ:LXRX), Corcept Therapeutics Incorporated (NASDAQ:CORT), Insys Therapeutics (NASDAQ:INSY), ANI Pharmaceuticals (NASDAQ:ANIP)

Colin Pettis02 mins

Lexicon Pharmaceuticals Inc. (NASDAQ:LXRX), just announced a positive, top-line result in a Phase 2 clinical trial of their experimental therapy LX4211 in type 1 diabetes. LX4211, an oral, first-in-class, dual inhibitor of sodium glucose transporters 1 and 2, was designed to lower blood glucose levels through two insulin-independent mechanisms of action. Lexicon Pharmaceuticals, Inc. (NASDAQ:LXRX)…

Read More

Biotech New Lows: ArQule (NASDAQ:ARQL), OvaScience Inc (NASDAQ:OVAS), Uniqure (NASDAQ:QURE), Egalet Corp (NASDAQ:EGLT)

Colin Pettis02 mins

ArQule Inc. (NASDAQ:ARQL) announced that the Company will present at the Needham 13th Annual Healthcare Conference. The presentation will be web cast and may be accessed through the investor relations section of the Company’s website http://www.arqule.com. ArQule, Inc. (NASDAQ:ARQL) stock performance was -2.92% in last session and finished the day at $1.66. Traded volume was…

Read More

Hot Movers: Sony Corp (ADR) (NYSE:SNE), Advanced Micro Devices (NYSE:AMD), NVIDIA Corporation (NASDAQ:NVDA), QUALCOMM (NASDAQ:QCOM)

Colin Pettis02 mins

Yesterday, Sony Corporation (ADR) (NYSE:SNE) announced that they are selling SCE’s 9,520,000 shares in Square Enix to one of the biggest Japanese brokerage firms, SMBC Nikko Securities. The analyst predicted that the deal will net Sony Corporation (ADR) (NYSE:SNE) 4.8 billion YEN which is “47 million dollars”. Sony Corp (ADR) (NYSE:SNE) stock performance was 1.24%…

Read More